Alzinova AB - Company & Market Research Reports

Alzinova AB is Swedish biotechnology enterprise engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company was founded in 2011 by the inventors of the AβCC peptide technology (patent pending) and MIVAC Development AB in close collaboration with the holding company at the University of Gothenburg in Sweden, GU Ventures AB. It is headquartered in Gothenburg, Sweden.

Alzheimer's Disease - Pipeline Review, H2 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2018

  • Drug Pipelines
  • 1333 Pages
From
Alzheimer's Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1203 Pages
From
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator
adroll